Lobbying

Advanced RX Pharmacy's latest lobbying report covers Q3 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Science/Technology.

Advanced RX Pharmacy

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Advanced RX Pharmacy lobbying by quarter
Advanced RX Pharmacy lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$30K1
Q2 2023$30K1
Q3 2023$30K1
Q4 2023$30K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$01
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Science and technology$210K · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

No house or agency named.

Firms it paid

Firm
Ballard Partners$210K8 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
24/10/21for Q3 2024Ballard PartnersUnder $5,000
24/07/19for Q2 2024Ballard Partners$30K
24/07/02for Q2 2024Ballard PartnersUnder $5,000
24/04/19for Q1 2024Ballard Partners$30K
24/01/17for Q4 2023Ballard Partners$30K
23/10/19for Q3 2023Ballard Partners$30K
23/07/18for Q2 2023Ballard Partners$30K
23/04/19for Q1 2023Ballard Partners$30K
23/01/18for Q4 2022Ballard Partners$30K